Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing

    NEXT STORY
    10x Genomics Reports First Quarter 2020 Financial Results
    PREV STORY
    Nabriva Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Updates
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    TiGenix announces closing of NASDAQ IPO

    Leuven (BELGIUM) - December 20, 2016, 16:00h CET - TiGenix NV (Euronext Brussels & NASDAQ: TIG; ...

    author_avatar
    NASDAQ Market News

    Sanofi affiche une croissance solide au deuxième trimestre 2019

    author_avatar
    NASDAQ Market News

    ContraFect Announces up to $18.9 Million in Funding from CARB-X to Support Acceleration of the CF-370 Program for Treating Pseudomonas aeruginosa Infections towards Clinical Stage Development

    author_avatar
    NASDAQ Market News